Amazon is taking another shot at becoming a regular health care source for customers with the launch of a service centered on virtual care.

The e-commerce giant says its Prime customers can now get quick access to a health care provider through a program that costs $9 a month or $99 annually.

The announcement arrives less than a year after Amazon announced the $3.9 billion acquisition of the membership-based primary care provider One Medical, which has medical offices in more than 20 markets.

The company has made a number of attempts to incorporate healthcare into its platform and has started building momentum after some initial setbacks.

The company announced in August that it was adding video telemedicine visits in all 50 states to a virtual clinic it launched last year.

Yet Amazon shut down a virtual health care service last year that it spent years developing, and it was part of a high-profile but failed push to address health care costs in a partnership with two other major companies, Berkshire Hathaway and JPMorgan.

Through the new service, patients will be able to connect virtually around the clock with care providers through its Prime One Medical membership program. The service includes video chats and an option to make in-person visits if there are One Medical locations near by.

The company said Wednesday that its membership fee covers the cost for the virtual visits. But customers would have to pay for any visits they make to the company’s One Medical primary care offices. They can use insurance for that.

Virtual care grew popular during the COVID-19 pandemic, and many health care providers have since expanded their telemedicine offerings. It has remained popular as a convenient way to check in with a doctor or deal with relatively minor health issues like pink eye.

While virtual visits can improve access to help, some doctors worry that they also lead to care fragmentation and can make it harder to track a patient’s overall health. That could happen if a patient has a regular doctor who doesn’t learn about the virtual visit from another provider.

Updated November 9, 2023 at 4:46 p.m. ET to add missing word in the seventh paragraph and correct "last summer" to "last year" in sixth paragraph.

Share:
More In Business
Medical Cannabis Company Akanda Sees Stock Surge in March's First IPO
Medical cannabis company Akanda went public this week in what was the first traditional IPO of the month. Shares jumped about 163% in the stock's first day of trading. The London-based company says it hopes to supply medical cannabis products to wholesalers in international markets. Tej Virk, CEO of Akanda, joins Cheddar News' Closing Bell to discuss.
Akeneo CEO on $135 Million Fundraise to Redefine Product Management
Software company Akeneo CEO Fred De Gombert joined Closing Bell to discuss its recently closed Series D funding round raising $135 million in its quest to redefine product information management. De Gombert said the company is set out to improve the product information category by harnessing the power of data, which comes at a time where customer behavior has shifted in the pandemic era. "We are more and more demanding as consumers when we are shopping online or even offline. We are looking for more and more information," De Gombert said.
Guinness Ambassador Joe Montana, Diageo Celebrate St. Patrick’s Day at NYSE
Guinness Ambassador and Pro Football Hall of Famer Joe Montana and Diageo CEO Nuno Teles got to ring the closing bell at the New York Stock Exchange to celebrate the St. Patrick’s Day holiday for the first time in two years. "We're just happy to be out here celebrating today. not only St. Patrick's Day, but the ability for all of us to get together again, right, and be able to celebrate St. Patrick's Day," said Montana. And with March 17th being the biggest day of the year for the Guinness brand, it comes amid supply chain woes. "Well, there's a high demand and with high demand, we need to really go and be more creative in the way we manage the supply," Teles said. "So we have been able to allocate product, making sure that everyone has what they need to go through this important period of the year, which is St. Patrick's."
Colossal CEO Says Its About Saving Biodiversity, Not Just Extinct Woolly Mammoth
Bioscience and genetic engineering company, Colossal, raised $60 million in a Series A funding round. Colossal is focused on developing new technologies and genetic tools to restore extinct species, and protect critically endangered species. One of the startup's long-term goals is to resurrect the woolly mammoth, and return it back to the arctic. Colossal also says it is developing technology that expands beyond animals, and has the potential to advance human health. Ben Lamm, co-founder and CEO of Colossal, joins Cheddar News' Closing Bell to discuss.
Load More